Pimecrolimus Cream 1% Plus Topical Corticosteroid in Patients (2-17 Years of Age) With Severe Atopic Dermatitis
Public ClinicalTrials.gov record NCT00121381. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT00121381
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Novartis
- Industry
- Enrollment
- 400 participants
Conditions and interventions
Conditions
Interventions
- Pimecrolimus plus topical corticosteroid (TCS) Drug
- Pimecrolimus vehicle (Placebo) plus topical corticosteroid (TCS) Drug
Drug
Eligibility (public fields only)
- Age range
- 2 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2005
- Primary completion
- Not listed
- Completion
- Dec 31, 2006
- Last update posted
- Jan 14, 2008
2005 – 2007
United States locations
- U.S. sites
- 13
- U.S. states
- 12
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pediatric Care Medical Group, Inc. | Huntington Beach | California | 92647 | — |
| Children's Hospital -San Diego | San Diego | California | 92123 | — |
| National Jewish Medical and Research Center | Denver | Colorado | 80206 | — |
| Dermatology Associates and Research | Coral Gables | Florida | 33134 | — |
| Medical College of Georgia - Clinical Investigative Services | Augusta | Georgia | 30912 | — |
| Dartmouth Hitchcock Medical Center Section of Dermatology | Lebanon | New Hampshire | 03756 | — |
| Wake Forest University School of Medicine Dept. of Dermatology | Winston-Salem | North Carolina | 27157 | — |
| Calcagno Research and Development | Gresham | Oregon | 97030 | — |
| Children's Hospital of Philadelphia | Philadelphia | Pennsylvania | 19104 | — |
| Rhode Island Hospital | Providence | Rhode Island | 02903 | — |
| 520 Trinity Creek Cove | Cordova | Tennessee | 38018 | — |
| Virginia Commonwealth University | Richmond | Virginia | 23298 | — |
| A.S.T.H.M.A., Inc | Seattle | Washington | 98105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00121381, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 14, 2008 · Synced May 11, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00121381 live on ClinicalTrials.gov.